BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8578549)

  • 1. Platelet disorders in uraemia before and after haemodialysis under the influence of low dose aspirin.
    Tschugguel W; Blaicher A; Kramer L; Felfernig M; Jüngling G; Kurz M; Gnant M; Zimpfer M
    Thromb Res; 1995 Nov; 80(3):225-33. PubMed ID: 8578549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate doses of aspirin and risk of bleeding in renal failure.
    Livio M; Benigni A; Viganò G; Mecca G; Remuzzi G
    Lancet; 1986 Feb; 1(8478):414-6. PubMed ID: 2868341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.
    Fernandez F; Goudable C; Sie P; Ton-That H; Durand D; Suc JM; Boneu B
    Br J Haematol; 1985 Jan; 59(1):139-48. PubMed ID: 3918557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting.
    Jámbor C; von Pape KW; Spannagl M; Dietrich W; Giebl A; Weisser H
    Anesth Analg; 2011 Jul; 113(1):31-9. PubMed ID: 21519054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
    Turi S; Soos J; Torday C; Bereczki C; Havass Z
    Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
    Gaspari F; Viganò G; Orisio S; Bonati M; Livio M; Remuzzi G
    J Clin Invest; 1987 Jun; 79(6):1788-97. PubMed ID: 3108321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding in renal failure.
    Remuzzi G
    Lancet; 1988 May; 1(8596):1205-8. PubMed ID: 2897015
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
    Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
    Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.
    Kawasaki T; Ozeki Y; Igawa T; Kambayashi J
    Stroke; 2000 Mar; 31(3):591-5. PubMed ID: 10700490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures.
    Kim JH; Baek CH; Min JY; Kim JS; Kim SB; Kim H
    Ann Hematol; 2015 Sep; 94(9):1457-61. PubMed ID: 25933676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
    Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
    Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-response of aspirin on platelet function in very elderly patients].
    Feng XR; Liu ML; Liu F; Fan Y; Tian QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):835-840. PubMed ID: 27752166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet life span in uraemia.
    Tanaka H; Umimoto K; Izumi N; Nishimoto K; Maekawa T; Kishimoto T; Maekawa M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():306-10. PubMed ID: 3991516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose acetylsalicylic acid and bleeding risks with ventriculoperitoneal shunt placement.
    Kamenova M; Croci D; Guzman R; Mariani L; Soleman J
    Neurosurg Focus; 2016 Sep; 41(3):E4. PubMed ID: 27581316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
    Komarnicki M; Zozulińska M; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
    Bloom A; Greaves M; Preston FE; Brown CB
    Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.